GLP-1 RA's Increase Blood Clot Risks
US$ 28.47
retatrutide type 2 diabetes phase 2 trial hba1c as a Novel Treatment for Obesity and ADA 2026: TRANSCEND-T2D-1: Retatrutide Demonstrates
Description
doi: 10.1111/bcp.14855 34 YangWSLeeWJFunahashiTTanakaSMatsuzawaYChaoCLet al
Membership starts at $99 per month
Keywords: diabetes, glucagon-like peptide 1 agonists, glucocorticoids, pharmacotherapy algorithm, steroid-induced diabetes 1
Can It Be Reversed
81 Notably, there was no increased risk even among patients with pre-existing psychiatric illness, including depression or prior self-harm
& Bes-Rastrollo, M
